Sign in
CompletedNo phase

Biomarkers for Pain in Spinal Cord Injury Patients

Key facts

Who runs it
The University of Texas Health Science Center, Houston
Where
Houston, United StatesSee the site
Trial code
Status
Completed
People taking part
120 people enrolled
Started
Jun 2009
Ended
Jun 2026
Type of study
Observational, 3 groups
Treatments tested
  • blood samples
Record updated
16 June 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 18 criteriaShow less

Other criteria

  • Chronic Patients; Inclusion:
  • Two or more years post traumatic SCI with deficit; Exclusion:
  • < 18 years of age
  • Evidence of brain injury on computed tomography (CT) (SCI patients need to be able to comply with completing the pain survey)
  • Other medical condition that accounts for chronic pain (i.e. diabetic neuropathy, renal insufficiency, multiple sclerosis, HIV associated neuropathy, alcohol-related neuropathy)
  • Temperature > 100.5°C
  • History of infection within the last 30 days (i.e. UTI, URI, pressure sore)
  • History of Pulmonary Embolus (PE) or deep vein thrombosis (DVT)
  • Inability to obtain informed consent
  • Psychiatric problems (patients need to be able to complete the pain survey)
  • Diagnosis or treatment of cancer in the last 5 years
  • Longitudinal, Prospective Cohort Patients:; Inclusion:
  • Initial traumatic SCI with deficit; Exclusion:; Same as listed above C. Healthy Volunteers Healthy volunteers include gender, age and race matched volunteers able to provide informed consent who have,
  • No significant medical history (pain free)
  • No recent infections
  • Take no medications
  • Fever free
  • Greater than 18 years old

Where in United States

  • Memorial Hermann HospitalHouston, United States

About the trial

What the trial wants to find out

The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these biomarkers manifest.

Read full original descriptionShow less

Our working hypothesis is that sustained alterations in specific inflammatory molecules are associated with chronic neuropathic pain following SCI, and that their plasma levels can serve as biomarkers to identify patients at risk for the development of neuropathic pain.

Additionally the investigators are collecting skin tissue biopsy samples from patients following acute and chronic spinal cord injury to create vector-free human iPS cells from fibroblasts by direct delivery of reprogramming proteins.

The 3 groups in the trial

  • Acute-Longitudinal SCI

    Treatment: blood samples

  • Chronic SCI

    Treatment: blood samples

  • Healthy volunteers

    Treatment: blood samples

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
Record updated
16 June 2026